XOLREMDI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
83296-100 -
Package NDC
83296-100-12 -
Package NDC
83296-100-60 -
Package NDC
83296-100-90 -
Application number
NDA218709 -
SPL ID
26bdd232-8068-9080-e063-6394a90aa084 -
SPL set ID
7f3a5ee3-ca73-4876-85a0-ed1e108a2237 -
UNII
0G9LGB5O2W -
RxCUI
2684026 -
RxCUI
2684032
What the source publishes
- Labeler
- X4 Pharmaceuticals, Inc.
- Active ingredients
- mavorixafor
- Form
- CAPSULE, GELATIN COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "XOLREMDI",
"splId": "26bdd232-8068-9080-e063-6394a90aa084",
"labels": [
{
"setId": "7f3a5ee3-ca73-4876-85a0-ed1e108a2237",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f3a5ee3-ca73-4876-85a0-ed1e108a2237",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f3a5ee3-ca73-4876-85a0-ed1e108a2237"
}
],
"routes": [
"ORAL"
],
"labeler": "X4 Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "120 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-12)",
"package_ndc": "83296-100-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20240521"
},
{
"sample": false,
"description": "60 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-60)",
"package_ndc": "83296-100-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20240521"
},
{
"sample": false,
"description": "90 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-90)",
"package_ndc": "83296-100-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20241101"
}
],
"productId": "83296-100_26bdd232-8068-9080-e063-6394a90aa084",
"useDomain": "unknown",
"dosageForm": "CAPSULE, GELATIN COATED",
"productNdc": "83296-100",
"deaSchedule": null,
"genericName": "mavorixafor",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MAVORIXAFOR",
"strength": "100 mg/1"
}
],
"applicationNumber": "NDA218709",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240521",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194104",
"N0000194105",
"N0000182137",
"N0000182141",
"N0000185503"
],
"unii": [
"0G9LGB5O2W"
],
"rxcui": [
"2684026",
"2684032"
],
"spl_set_id": [
"7f3a5ee3-ca73-4876-85a0-ed1e108a2237"
],
"pharm_class_epc": [
"CXC Chemokine Receptor 4 Antagonist [EPC]"
],
"pharm_class_moa": [
"CXC Chemokine Receptor 4 Antagonists [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"X4 Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:83296-100_26bdd232-8068-9080-e063-6394a90aa084"